What's in Ventrus Biosciences, Inc's pipeline?

Ventrus Biosciences, Inc has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ventrus Biosciences, Inc's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Ain Shams University, Bioprojet, Boryung Pharmaceutical Co., Ltd, Bristol-Myers Squibb.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ventrus-biosciences-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Ventrus Biosciences, Inc — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ventrus Biosciences, Inc pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
VEN 307	VEN 307	phase 3	Rho kinase inhibitor	Rho kinase (ROCK)	Ophthalmology
Diltiazem Hydrochloride 2% Cream	Diltiazem Hydrochloride 2% Cream	phase 3	Calcium channel blocker	L-type calcium channels	Dermatology / Pain Management

Therapeutic area mix

Dermatology / Pain Management · 1
Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 2 shared drug classes
Ain Shams University · 1 shared drug class
Bioprojet · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
Addpharma Inc. · 1 shared drug class
Handok Inc. · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ventrus Biosciences, Inc:

Cite this brief

Drug Landscape (2026). Ventrus Biosciences, Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ventrus-biosciences-inc. Accessed 2026-05-16.